Hormone Refractory Prostate Cancer (HRPCA) Market Report

Global and China Hormone Refractory Prostate Cancer (HRPCA) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 02, 2022
  • PAGES：203
  • REPORT CODE：GMM1337381
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth.

    This report elaborates on the current development of the Hormone Refractory Prostate Cancer (HRPCA) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Astellas Inc

    • Dendreon Corporation, Bayer AG

    • Johnson & Johnson

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Chemotherapy

    • Hormonal Therapy

    • Immunotherapy

    • Radiation Therapy

    • Surgery

    Application:

    • Hospitals

    • Ambulatory Surgical Centers

    • Specialty Clinics

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Hormone Refractory Prostate Cancer (HRPCA) Industry Overview

      • 1.1.1 Hormone Refractory Prostate Cancer (HRPCA) Market Scope and Market Segments

      • 1.1.2 Hormone Refractory Prostate Cancer (HRPCA) Industry Characteristics

      • 1.1.3 Global and China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Hormone Refractory Prostate Cancer (HRPCA) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Chemotherapy

      • 1.2.2 Hormonal Therapy

      • 1.2.3 Immunotherapy

      • 1.2.4 Radiation Therapy

      • 1.2.5 Surgery

    • 1.3 Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Ambulatory Surgical Centers

      • 1.3.3 Specialty Clinics

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Hormone Refractory Prostate Cancer (HRPCA) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Hormone Refractory Prostate Cancer (HRPCA) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Hormone Refractory Prostate Cancer (HRPCA) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Hormone Refractory Prostate Cancer (HRPCA) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Hormone Refractory Prostate Cancer (HRPCA) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Hormone Refractory Prostate Cancer (HRPCA) Industry PEST Analysis

    • 2.3 Hormone Refractory Prostate Cancer (HRPCA) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Hormone Refractory Prostate Cancer (HRPCA) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Hormone Refractory Prostate Cancer (HRPCA) Industry

    Chapter 3 Global and China Hormone Refractory Prostate Cancer (HRPCA) Market, by Manufacturer

    • 3.1 Global and China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Hormone Refractory Prostate Cancer (HRPCA) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Hormone Refractory Prostate Cancer (HRPCA) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Hormone Refractory Prostate Cancer (HRPCA) Market Top 3 Players

    Chapter 4 Global and China Hormone Refractory Prostate Cancer (HRPCA) Market, by Type (2017-2028)

    • 4.1 Hormone Refractory Prostate Cancer (HRPCA) Market Trend, by Type

    • 4.2 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Hormone Refractory Prostate Cancer (HRPCA) Price Trend, by Type (2017-2028)

    • 4.3 China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Hormone Refractory Prostate Cancer (HRPCA) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Hormone Refractory Prostate Cancer (HRPCA) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Hormone Refractory Prostate Cancer (HRPCA) Market Analysis

    • 7.1 North America Hormone Refractory Prostate Cancer (HRPCA) Market, by Type

    • 7.2 North America Hormone Refractory Prostate Cancer (HRPCA) Market, by Application

    • 7.3 North America Hormone Refractory Prostate Cancer (HRPCA) Market Analysis and Forecast, by Country

      • 7.3.1 United States Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Hormone Refractory Prostate Cancer (HRPCA) Market Analysis

    • 8.1 Europe Hormone Refractory Prostate Cancer (HRPCA) Market, by Type

    • 8.2 Europe Hormone Refractory Prostate Cancer (HRPCA) Market, by Application

    • 8.3 Europe Hormone Refractory Prostate Cancer (HRPCA) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Hormone Refractory Prostate Cancer (HRPCA) Market Analysis

    • 9.1 APAC Hormone Refractory Prostate Cancer (HRPCA) Market, by Type

    • 9.2 APAC Hormone Refractory Prostate Cancer (HRPCA) Market, by Application

    • 9.3 APAC Hormone Refractory Prostate Cancer (HRPCA) Market Analysis and Forecast, by Country

      • 9.3.1 China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Market Analysis

    • 10.1 Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Market, by Type

    • 10.2 Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Market, by Application

    • 10.3 Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Hormone Refractory Prostate Cancer (HRPCA) Company Profiles

      • 11.1 Astellas Inc

        • 11.1.1 Astellas Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Product Profiles, Application and Specification

        • 11.1.3 Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Dendreon Corporation, Bayer AG

        • 11.2.1 Dendreon Corporation, Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Product Profiles, Application and Specification

        • 11.2.3 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Johnson & Johnson

        • 11.3.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Product Profiles, Application and Specification

        • 11.3.3 Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Hormone Refractory Prostate Cancer (HRPCA) Industry Investment Prospect and Risk Assessment

    • 12.1 Hormone Refractory Prostate Cancer (HRPCA) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Hormone Refractory Prostate Cancer (HRPCA) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Production Value and Growth Rate (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Production Value and Growth Rate (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate of Chemotherapy (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate of Hormonal Therapy (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate of Immunotherapy (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate of Radiation Therapy (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate of Surgery (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate of Ambulatory Surgical Centers (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size and Growth Rate of Specialty Clinics (2017-2028)

    • Figure North America Hormone Refractory Prostate Cancer (HRPCA) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Hormone Refractory Prostate Cancer (HRPCA) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Hormone Refractory Prostate Cancer (HRPCA) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Hormone Refractory Prostate Cancer (HRPCA) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Hormone Refractory Prostate Cancer (HRPCA) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Hormone Refractory Prostate Cancer (HRPCA) Market Share, by Manufacturer in 2021

    • Figure Global and China Hormone Refractory Prostate Cancer (HRPCA) Market Share, by Manufacturer in 2022

    • Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Type (2017-2028)

    • Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Value, by Type (2017-2028)

    • Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Value Share, by Type (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Price Trend, by Type (2017-2028)

    • Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Type (2017-2028)

    • Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Value, by Type (2017-2028)

    • Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Value Share, by Type (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Price Trend, by Type (2017-2028)

    • Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Application (2017-2028)

    • Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Value, by Application (2017-2028)

    • Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Value Share, by Application (2017-2028)

    • Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Value Share, by Application (2017-2028)

    • Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Application (2017-2028)

    • Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Value, by Application (2017-2028)

    • Table China Hormone Refractory Prostate Cancer (HRPCA) Sales Value Share, by Application (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Value Share, by Application (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Production, Import, Consumption and Export (2017-2022)

    • Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Type (2017-2028)

    • Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Figure North America Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Application (2017-2028)

    • Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure North America Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure United States Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Type (2017-2028)

    • Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Application (2017-2028)

    • Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure UK Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure France Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure France Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Table APAC Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Type (2017-2028)

    • Table APAC Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Table APAC Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Application (2017-2028)

    • Table APAC Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure India Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure India Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Hormone Refractory Prostate Cancer (HRPCA) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Hormone Refractory Prostate Cancer (HRPCA) Sales Value and Growth Rate (2017-2028)

    • Table Astellas Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Inc Product Profiles, Application and Specification

    • Table Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dendreon Corporation, Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dendreon Corporation, Bayer AG Product Profiles, Application and Specification

    • Table Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US